Innovation & Collaboration Program
The Lustgarten Foundation’s Innovation and Collaboration Program provides seed funding for investigators who have highly innovative research with significant potential to accelerate the mission to transform pancreatic cancer into a curable disease. Each recipient is awarded a one-year, $110,000 grant for their pancreatic cancer research.
REQUEST FOR APPLICATIONS
- Applications must be submitted through ProposalCentral by January 5, 2024
- Applicants selected for funding will be notified by April, with the earliest anticipated start in June.
- Read the complete RFA Details for more information.
2023 Recipients
Kacper Rogala, DPhil, MRes, Assistant Professor of Structural Biology and of Chemical and Systems Biology, Stanford University School of Medicine, for his study “Establishing Choline Transport as Selective Vulnerability of Pancreatic Cancers.”
David Kashatus, PhD, Associate Professor, Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, for his study “The Role of Lipid Droplets in Pancreatic Cancer Metastasis.”
2022 Recipients
Mandar Muzumdar, MD, Co-Director of Pancreas Program, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yake Cancer Center, for his study “Dietary Oleic Acid Reprograms Pancreatic Lipid Metabolism to Drive Cancer Development.”
Andrew Lowy, MD, Director of Surgical Oncology at UC San Diego and Associate Director, Moores Cancer Center, for his study “Building on KRAS Inhibition in Pancreas Cancer: Defining Rational Pairings to Combat Resistance and Enhance Responses to Immunotherapy.”